Bangalore India Bio 2010.

Idrugs Pub Date : 2010-08-01

Pratibha Thammanabhatla, Mamatha Pailla

引用次数: 0

Abstract

The Bangalore India Bio 2010 conference, held in Bangalore, India, included topics covering new developments in the biopharma industry. This conference report highlights selected presentations on novel therapeutics for the treatment of cancer, including identification of novel benzimidazole, N-subsituted isatin and azetidine derivatives, and an Wnt antagonist. In addition, presentations from several biopharma companies and universities are highlighted, including Proteomics International Pty Ltd, Oxford BioMedica plc, AnaptysBio Inc, SIOGEN Biotech, RV College of Engineering and Indian Institute of Science.

本刊更多论文

班加罗尔印度生物2010。

在印度班加罗尔举行的2010年班加罗尔印度生物大会的主题涵盖了生物制药行业的新发展。本次会议报告重点介绍了治疗癌症的新疗法，包括新型苯并咪唑、n -取代isatin和氮杂啶衍生物的鉴定，以及一种Wnt拮抗剂。此外，几家生物制药公司和大学的演讲也得到了重视，包括Proteomics International Pty Ltd, Oxford BioMedica plc, AnaptysBio Inc, SIOGEN Biotech, RV工程学院和印度科学研究所。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Idrugs 医学-药学

自引率

0.00%

发文量

审稿时长

>12 weeks